Sep 10, 2018
This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

Pune, India - September 10, 2018 /MarketersMedia/ —
This report studies the global market size of Specialty Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Specialty Pharmaceuticals in these regions.
This research report categorizes the global Specialty Pharmaceuticals market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs.
North America accounts the significant market share due to high buying power and reimbursement for the specialty pharmaceuticals are the major factors boosting the growth of this market during the forecast period.
In 2017, the global Specialty Pharmaceuticals market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Specialty Pharmaceuticals market based on company, product type, application and key regions.
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3387810-global-specialty-pharmaceuticals-market-insights-forecast-to-2025
The various contributors involved in the value chain of Specialty Pharmaceuticals include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Specialty Pharmaceuticals include
Teva Pharmaceuticals
Abbvie
Amgen
Johnson & Johnson
Celgene
Gilead Sciences
Roche
Market Size Split by Type
Oral Pharmaceuticals
Parenteral Pharmaceuticals
Transdermal Pharmaceuticals
Market Size Split by Application
Hospitals
Retail Pharmacies
Specialty Pharmacies
Mail Order
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Specialty Pharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Specialty Pharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Specialty Pharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Specialty Pharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Specialty Pharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents - Key Points
1 Study Coverage
1.1 Specialty Pharmaceuticals Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Specialty Pharmaceuticals Market Size Growth Rate by Type
1.4.2 Oral Pharmaceuticals
1.4.3 Parenteral Pharmaceuticals
1.4.4 Transdermal Pharmaceuticals
1.5 Market by Application
1.5.1 Global Specialty Pharmaceuticals Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Retail Pharmacies
1.5.4 Specialty Pharmacies
1.5.5 Mail Order
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Specialty Pharmaceuticals Market Size
2.1.1 Global Specialty Pharmaceuticals Revenue 2016-2025
2.1.2 Global Specialty Pharmaceuticals Sales 2016-2025
2.2 Specialty Pharmaceuticals Growth Rate by Regions
2.2.1 Global Specialty Pharmaceuticals Sales by Regions
2.2.2 Global Specialty Pharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Specialty Pharmaceuticals Sales by Manufacturers
3.1.1 Specialty Pharmaceuticals Sales by Manufacturers
3.1.2 Specialty Pharmaceuticals Sales Market Share by Manufacturers
3.1.3 Global Specialty Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Specialty Pharmaceuticals Revenue by Manufacturers
3.2.1 Specialty Pharmaceuticals Revenue by Manufacturers (2016-2018)
3.2.2 Specialty Pharmaceuticals Revenue Share by Manufacturers (2016-2018)
3.3 Specialty Pharmaceuticals Price by Manufacturers
3.4 Specialty Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Specialty Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Specialty Pharmaceuticals Product Category
3.4.3 Date of International Manufacturers Enter into Specialty Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
............
11 Company Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Specialty Pharmaceuticals
11.1.4 Specialty Pharmaceuticals Product Description
11.1.5 Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Specialty Pharmaceuticals
11.2.4 Specialty Pharmaceuticals Product Description
11.2.5 Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Specialty Pharmaceuticals
11.3.4 Specialty Pharmaceuticals Product Description
11.3.5 Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Specialty Pharmaceuticals
11.4.4 Specialty Pharmaceuticals Product Description
11.4.5 Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Specialty Pharmaceuticals
11.5.4 Specialty Pharmaceuticals Product Description
11.5.5 Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Specialty Pharmaceuticals
11.6.4 Specialty Pharmaceuticals Product Description
11.6.5 Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Specialty Pharmaceuticals
11.7.4 Specialty Pharmaceuticals Product Description
11.7.5 Recent Development
……Continued
Access Complete Report @ https://www.wiseguyreports.com/reports/3387810-global-specialty-pharmaceuticals-market-insights-forecast-to-2025
Contact Info:
Name: Norah Trent
Email: [email protected]
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349 (US) +44 208 133 9349 (UK)
For more information, please visit https://www.wiseguyreports.com/
Source: MarketersMedia
Release ID: 405333
Drugs reportedly worth RM784m.
Moonshot says it removed cyber-related data from the training corpus and reinforcement-learning environments used to develop the model, while retaining general coding skills
MANILA, Philippines — The government on Friday placed a P50-million bounty on the head of Sen. Ronald “Bato” dela Rosa as the Philippine National Police gave its former chief one week to surrender to face trial in the International Criminal Court (ICC) alongside ex-President Rodrigo Duterte for crimes against humanity in their war on drugs.
COTABATO CITY — A former member of parliament (MP) of the Bangsamoro Autonomous Region in Muslim Mindanao (BARMM) denied allegations by law enforcement officials that he was behind the recent foiled shipment of illegal drugs from Laos. In an undated video message posted on social media Thursday night, Sultan Edrieza Hadji Nasser Rimbang maintained that
MANILA, Philippines — Palace press officer Claire Castro will remain the Marcos administration’s chief mouthpiece following a recent leadership change in the Presidential Communications Office (PCO). PCO acting chief and Secretary Lino Cayetano on Friday confirmed that Castro was staying put even as other appointees from the previous leadership had tendered their courtesy resignations. “Usec
MANILA, Philippines — Davao City Rep. Paolo “Pulong” Duterte on Friday filed libel and cyberlibel complaints against several individuals, a television network and its officials and journalists over allegations of bribery that he said were “untrue” and meant to destroy his reputation. Duterte, who personally appeared at the Davao City Prosecutor’s Office, filed the complaints
MANILA, Philippines — The Department of Transportation (DOTr) on Friday announced it will bid out next year the P103.6-billion concession for Metro Rail Transit Line 3 (MRT-3). “Through public-private partnership, we bring in the expertise and investment this line needs,” Transportation Secretary Giovanni Lopez said in a statement by his agency. “What we need here
Maomao and Jinshi find themselves investigating a mysterious case involving a deceased imperial concubine in the newly released trailer for “The Apothecary Diaries: The Late Lady"s Treasure.”
MANILA, Philippines — President Ferdinand Marcos Jr. on Friday said the government is expanding the use of solar-powered irrigation systems amid the threat of the Super El Niño anticipated by year-end until early 2027. He made the remarks during the inauguration of the Tugbong Solar Pump Irrigation Project (SPIP) in Barangay Tugbong, Kananga, Leyte. “All
MANILA, Philippines — There is no need for the House of Representatives to recall its 2027 General Appropriations Bill (GAB) in response to a recent Supreme Court decision which declared as unconstitutional key provisions of the 2024 to 2026 national budgets, according to two Senate leaders. Senate President Sherwin Gatchalian said the high court’s Oct.
A new price hike for diesel is expected next week due to worsening geopolitical conflicts. In an advisory on Friday, Jetti Petroleum president Leo Bellas said diesel prices may increase by P2 to P2.50 per liter. But motorists may also get small relief, with gasoline scheduled for a rollback of P1 to P1.50 per liter.
MANILA, Philippines — The Land Transportation Office (LTO) will deploy more than 100 personnel under “Oplan Biyaheng Ayos–Undas 2026” to ensure road safety and orderly traffic with the expected surge in travelers. READ: Undas practices continue at home for those absent in cemeteries, columbaria The deployment will cover Manila-Cavite Expressway, South Luzon Expressway, Skyway, STAR
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.